Gender Differences in Outpatient Pediatric Drug Utilization: A Cohort Study From Southern Italy

Frontiers in Pharmacology
Carmen FerrajoloAnnalisa Capuano

Abstract

Objective: The aim of this retrospective population-based cohort study is to in-depth investigate gender-specific drug utilization pattern in pediatric outpatient population. Methods: By using a large administrative database of the Local Health Unit of Caserta (Southern Italy), a pediatric cohort from the birth to 18 years was observed over 6 years (from 1st January 2010 to 31st December 2015). Yearly prevalence of drug use per 100 inhabitants as well as the median number of prescriptions was stratifying by gender. Prevalence of acute and recurrent use of the most frequently used active substances was calculated for the year 2015. Results: A decreasing trend in prevalence of drug use (-3.2%, with a reduction of median number of drugs dispensed) was observed in children for both sexes, from 2010 to 2015. In 2015, the drug classes most commonly used among children of any age were modestly but consistently prescribed more to males than to females: systemic anti-infective drugs (M = 43.5%; F = 42.3%), respiratory tract drugs (M = 29.0%; F = 26.1%), and hormones (M = 13.1%; F = 11.3%). Irrespective of gender, beclomethasone was the most utilized active substance in the first 2 years of life, while thereafter amoxicillin/clavulanate ...Continue Reading

References

Jan 5, 2002·European Journal of Clinical Pharmacology·T CazzatoUNKNOWN ACP Puglia-Basilicata Working Group
Dec 4, 2002·The Journal of Antimicrobial Chemotherapy·Alberto VaccheriNicola Montanaro
Feb 4, 2003·Pediatrics·Eric SchirmLolkje T W de Jong-van den Berg
Oct 6, 2006·European Journal of Clinical Pharmacology·Marta Luisa Ciofi degli AttiUNKNOWN SPES study group
Sep 25, 2007·European Journal of Clinical Pharmacology·Alessandra RossignoliMaurizio Bonati
May 1, 2008·European Journal of Pediatrics·Antonio ClavennaMaurizio Bonati
Nov 26, 2008·BMJ : British Medical Journal·Miriam C J M SturkenboomUNKNOWN TEDDY European Network of Excellence
Jun 17, 2009·European Journal of Clinical Pharmacology·Antonio Clavenna, Maurizio Bonati
Jun 18, 2009·Archives of Disease in Childhood·A Clavenna, M Bonati
Jun 26, 2009·British Journal of Clinical Pharmacology·Antonio ClavennaMaurizio Bonati
Sep 16, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Padmaja SubbaraoMalcolm R Sears
Sep 3, 2010·European Journal of Pediatrics·Elif Fatma SenUNKNOWN TEDDY European Network of Excellence
Apr 26, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kristina StarI Ralph Edwards
Dec 7, 2011·Expert Review of Clinical Pharmacology·John van den Anker, Karel Allegaert
Jun 16, 2012·European Urology·Serdar TekgülUNKNOWN European Association of Urology
Apr 6, 2013·BMC Pediatrics·Daniele PiovaniUNKNOWN Interregional Italian Drug Utilisation Group
Jan 1, 2014·PloS One·Francesco NapolitanoItalo F Angelillo
Jun 29, 2014·Nutrición hospitalaria·Romilda Castro De Andrade CairoCibele Dantas Ferreira Marques
May 15, 2015·Cell Host & Microbe·Pajau VangayDan Knights
Apr 25, 2016·European Journal of Epidemiology·Marina BianchiMaurizio Bonati

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.